Mail

UK markets closed

FTSE 100
8,420.26
-18.39(-0.22%)
FTSE 250
20,749.90
-72.94(-0.35%)
AIM
794.02
+1.52(+0.19%)
GBP/EUR
1.1678
+0.0023(+0.20%)
GBP/USD
1.2706
+0.0035(+0.28%)
Bitcoin GBP
52,692.57
+1,335.25(+2.60%)

9 houses with great-looking gardens

Check out these homes if inspiring outside space tops your property wish list

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF)

Other OTC - Other OTC Delayed price. Currency in USD

Add to watchlist

1.6950

+0.1050

(+6.60%)

At close: 03:49PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	7.92B
Enterprise value	10.67B
Trailing P/E	15.34
Forward P/E	10.81
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	0.76
Price/book (mrq)	0.66
Enterprise value/revenue	1.89
Enterprise value/EBITDA	17.98

Trading information

Stock price history

Beta (5Y monthly)	0.67
52-week change ³	-38.48%
S&P500 52-week change ³	26.49%
52-week high ³	2.8690
52-week low ³	1.5150
50-day moving average ³	1.6341
200-day moving average ³	2.0386

Share statistics

Avg vol (3-month) ³	7.96k
Avg vol (10-day) ³	10.18k
Shares outstanding ⁵	551.94M
Implied shares outstanding ⁶	4.98B
Float ⁸	1.7B
% held by insiders ¹	14.13%
% held by institutions ¹	21.21%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	0.06
Forward annual dividend yield ⁴	3.69%
Trailing annual dividend rate ³	0.27
Trailing annual dividend yield ³	16.98%
5-year average dividend yield ⁴	1.95
Payout ratio ⁴	55.96%
Dividend date ³	N/A
Ex-dividend date ⁴	31 Jul 2023
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	4.94%
Operating margin (ttm)	9.65%

Management effectiveness

Return on assets (ttm)	0.61%
Return on equity (ttm)	4.56%

Income statement

Revenue (ttm)	40.69B
Revenue per share (ttm)	15.26
Quarterly revenue growth (yoy)	-6.60%
Gross profit (ttm)	N/A
EBITDA	3.87B
Net income avi to common (ttm)	2.01B
Diluted EPS (ttm)	0.1000
Quarterly earnings growth (yoy)	-38.20%

Balance sheet

Total cash (mrq)	15.02B
Total cash per share (mrq)	5.62
Total debt (mrq)	34.9B
Total debt/equity (mrq)	60.66%
Current ratio (mrq)	1.01
Book value per share (mrq)	17.34

Cash flow statement

Operating cash flow (ttm)	3.46B
Levered free cash flow (ttm)	-2.51B